Targeting apoptosis via chemical design: Inhibition of bid-induced cell death by small organic molecules

Chemistry and Biology

Volumn 11, Issue 8, 2004, Pages 1107-1117

  Becattini, Barbara ^a   Sareth, Sina ^a   Zhai, Dayong ^a   Crowell, Kevin J ^a   Leone, Marilisa ^a   Reed, John C ^a   Pellecchia, Maurizio ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BID PROTEIN, HUMAN; CARRIER PROTEIN; DRUG; LIGAND; PROTEIN BID;

ANIMAL; APOPTOSIS; ARTICLE; BINDING SITE; BIOASSAY; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN TERTIARY STRUCTURE; SYNTHESIS;

ANIMALS; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BINDING SITES; BIOLOGICAL ASSAY; CARRIER PROTEINS; CELL LINE; DRUG DESIGN; HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS; PROTEIN STRUCTURE, TERTIARY;

EID: 4344616982     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.05.022     Document Type: Article

References (50)

1. Reed J.C. Bcl-2 family proteins. Oncogene. 17:1998;3225-3236
2. Adams J.M., Cory S. The Bcl-2 protein family arbiters of cell survival. Science. 281:1998;1322-1326
3. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1999;1899-1911
4. Cory S., Adams J.M. The Bcl2 family regulators of the cellular life-or-death switch. Nat. Rev. Cancer. 2:2002;647-656
5. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501
6. Deng Y., Ren X., Yang L., Lin Y., Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell. 115:2003;61-70
7. McDonnell J.M., Fushman D., Milliman C.L., Korsmeyer S.J., Cowburn D. Solution structure of the proapoptotic molecule BID a structural basis for apoptotic agonists and antagonists. Cell. 96:1999;625-634
8. Degli Esposti M. The roles of Bid. Apoptosis. 7:2002;433-440
9. Gross A., Yin X.M., Wang K., Wei M.C., Jockel J., Milliman C., Erdjument-Bromage H., Tempst P., Korsmeyer S.J. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274:1999;1156-1163
10. Brustovetsky N., Dubinsky J.M., Antonsson B., Jemmerson R. Two pathways for tBID-induced cytochrome c release from rat brain mitochondria BAK- versus BAX-dependence. J. Neurochem. 84:2003;196-207
11. Yin X.M., Wang K., Gross A., Zhao Y., Zinkel S., Klocke B., Roth K.A., Korsmeyer S.J. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature. 400:1999;886-891
12. Waldmeier P.C. Prospects for antiapoptotic drug therapy of neurodegenerative diseases. Prog. Neuropsychopharmacol. Biol. Psychiatry. 27:2003;303-321
13. Guegan C., Vila M., Teismann P., Chen C., Onteniente B., Li M., Friedlander R.M., Przedborski S., Teissman P. Instrumental activation of bid by caspase-1 in a transgenic mouse model of ALS. Mol. Cell. Neurosci. 20:2002;553-562
14. Sattler M., Liang H., Nettesheim D., Meadows R.P., Harlan J.E., Eberstadt M., Yoon H.S., Shuker S.B., Chang B.S., Minn A.J., et al. Structure of Bcl-xL-Bak peptide complex recognition between regulators of apoptosis. Science. 275:1997;983-986
15. Degterev A., Lugovskoy A., Cardone M., Mulley B., Wagner G., Mitchison T., Yuan J. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat. Cell Biol. 3:2001;173-182
16. Tzung S.P., Kim K.M., Basanez G., Giedt C.D., Simon J., Zimmerberg J., Zhang K.Y., Hockenbery D.M. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nat. Cell Biol. 3:2001;183-191
17. Kitada S., Leone M., Sareth S., Zhai D., Reed J.C., Pellecchia M. Discovery, characterization and structure-activity relationships studies of pro-apoptotic polyphenols targeting Bcl-xL. J. Med. Chem. 46:2003;4259-4264
18. Leone M., Zhai D., Sareth S., Kitada S., Reed J.C., Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 63:2003;8118-8121
19. Becattini B., Kitada S., Leone M., Monosov E., Chandler S., Zhai D., Kipps T.J., Reed J.C., Pellecchia M. Rational design and real time in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-XL. Chem. Biol. 11:2004;389-395
20. Huang Z. The chemical biology of apoptosis. Exploring protein-protein interactions and the life and death of cells with small molecules. Chem. Biol. 9:2002;1059-1072
21. O'Neill J.W., Hockenbery D.M. Bcl-2-related proteins as drug targets. Curr. Med. Chem. 10:2003;1553-1562
22. Osford S.M., Dallman C.L., Johnson P.W., Ganesan A., Packham G. Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells. Curr. Med. Chem. 11:2004;1031-1039
23. Chou J.J., Li H., Salvesen G.S., Yuan J., Wagner G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell. 96:1999;615-624
24. Fejzo J., Lepre C.A., Peng J.W., Bemis G.W., Ajay, Murcko M.A., Moore J.M. The SHAPES strategy an NMR-based approach for lead generation in drug discovery. Chem. Biol. 6:1999;755-769
25. Shuker S.B., Hajduk P.J., Meadows R.P., Fesik S.W. Discovering high-affinity ligands for proteins SAR by NMR. Science. 274:1996;1531-1534
26. Bemis G.W., Murcko M.A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 39:1996;2887-2893
27. Pellecchia M., Sem D.S., Wuthrich K. NMR in drug discovery. Nat. Rev. Drug Discov. 1:2002;211-219
28. Ni F. Recent developments in transferred NOEs methods. Prog. Nucleic Magn. Reson. Spectrosc. 26:1994;517-606
29. Mayer M., Meyer B. Mapping the active site of angiotensin-converting enzyme by transferred NOE spectroscopy. J. Med. Chem. 43:2000;2093-2099
30. Kumar A., Ernst R.R., Wuthrich K. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem. Biophys. Res. Commun. 95:1980;1-6
31. Jahnke W., Florsheimer A., Blommers M.J., Paris C.G., Heim J., Nalin C.M., Perez L.B. Second-site NMR screening and linker design. Curr. Top. Med. Chem. 3:2003;69-80
32. Li D., DeRose E.F., London R.E. The inter-ligand Overhauser effect a powerful new NMR approach for mapping structural relationships of macromolecular ligands. J. Biomol. NMR. 15:1999;71-76
33. Pellecchia M., Meininger D., Dong Q., Chang E., Jack R., Sem D.S. NMR-based structural characterization of large protein-ligand interactions. J. Biomol. NMR. 22:2002;165-173
34. Zerbe O. BioNMR in Drug Research. 2003;Wiley-VCH, Weinheim, Germany
35. Kline A. Sar by noe? The NMR Newsletter. 13:1997;472
36. Pervushin K., Riek R., Wider G., Wuthrich K. Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. USA. 94:1997;12366-12371
37. Kramer B., Rarey M., Lengauer T. Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins. 37:1999;228-241
38. Sheehan J.C., Preston J., Cruickshank P.A. A rapid synthesis of oligopeptide derivatives without isolation of intermediates. J. Am. Chem. Soc. 87:1965;2492-2493
39. Kamal A., Ramesh G., Laxman N., Ramulu P., Srinivas O., Neelima K., Kondapi A.K., Sreenu V.B., Nagarajaram H.A. Design, synthesis, and evaluation of new noncross-linking pyrrolobenzodiazepine dimers with efficient DNA binding ability and potent antitumor activity. J. Med. Chem. 45:2002;4679-4688
40. Korsmeyer S.J., Wei M.C., Saito M., Weiler S., Oh K.J., Schlesinger P.H. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ. 7:2000;1166-1173
41. Lynden P., Wahlgren N.G. Mechanisms of action of neuroprotectants in stroke. J. Stroke Cerebravasc. Dis. 9:2000;9-14
42. Friedlander R.M. Apoptosis and caspases in neurodegenerative diseases. N. Engl. J. Med. 348:2003;1365-1375
43. Li D., Levy L.A., Gabel S.A., Lebetkin M.S., DeRose E.F., Wall M.J., Howell E.E., London R.E. Interligand Overhauser effects in type II dihydrofolate reductase. Biochemistry. 40:2001;4242-4252
44. Wei M.C., Lindsten T., Mootha V.K., Weiler S., Gross A., Ashiya M., Thompson C.B., Korsmeyer S.J. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14:2000;2060-2071
45. Chittenden T. BH3 domains intracellular death-ligands critical for initiating apoptosis. Cancer Cell. 2:2002;165-166
46. Scorrano L., Korsmeyer S.J. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem. Biophys. Res. Commun. 304:2003;437-444
47. Schendel S.L., Azimov R., Pawlowski K., Godzik A., Kagan B.L., Reed J.C. Ion channel activity of the BH3 only Bcl-2 family member, BID. J. Biol. Chem. 274:1999;21932-21936
48. Clark R.D., Strizhev A., Leonard J.M., Blake J.F., Matthew J.B. Consensus scoring for ligand/protein interactions. J. Mol. Graph. Model. 20:2002;281-295
49. Teschner M., Henn C., Vollhardt H., Reiling S., Brickmann J. Texture mapping a new tool for molecular graphics. J. Mol. Graph. 12:1994;98-105
50. Zhai D., Ke N., Zhang H., Ladror U., Joseph M., Eichinger A., Godzik A., Ng S.C., Reed J.C. Characterization of the anti-apoptotic mechanism of Bcl-B. Biochem. J. 376:2003;229-236